LAKIN DIETEL: Open Payments
NPI 1336658780 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 38 payments from 13 companies in 2025. Trend: 2023 $432 · 2024 $1,138 · 2025 $872
Food & beverage: $872
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $219 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $205 |
| Novartis Pharmaceuticals Corporation | 4 | $141 |
| ABBVIE INC. | 3 | $60 |
| Janssen Biotech, Inc. | 3 | $51 |
| UCB, Inc. | 2 | $43 |
| LEO Pharma Inc. | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| Journey Medical Corporation | 1 | $21 |
Products named: Otezla, ILUMYA, TREMFYA, Bimzelx, SKYRIZI, Winlevi, ADBRY, DUPIXENT.
Industry payments across IN — which companies pay providers there.
